triiodothyronine has been researched along with kb 2115 in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hashizume, K; Ichikawa, K; Kikuchi, N; Matsuzawa, A; Miyamoto, T; Nagano, R; Nakamura, T; Ohnota, H; Ozawa, T; Shiohara, H | 1 |
Asano, Y; Maeda, K; Takahashi, N; Watanabe, N | 1 |
Banner, B; Conde-Knape, K; Danzi, S; Dvorozniak, M; Haynes, NE; Huang, KS; Kelly, MJ; Klein, I; Larigan, JD; Mennona, F; Pietranico-Cole, S; Qian, Y; Reynolds, CH; Scott, N; So, SS; Taub, R; Thakkar, K; Tilley, J; Vermeulen, J | 1 |
Josseaume, C; Lorcy, Y | 1 |
Angelin, B; Baxter, JD; Carlsson, B; Klein, I; Kristensen, JD; Ladenson, PW; Olsson, AG; Ridgway, EC | 1 |
Baxter, JD; Gustafsson, JÅ; Hsueh, WA; Lin, JZ; Martagón, AJ; Phillips, KJ; Webb, P | 1 |
Boilard, E; Levesque, T; Park, EA; Sharma, P | 1 |
Angelin, B; Carlsson, B; Chester Ridgway, E; Eriksson, M; Klein, I; Kristensen, JD; Ladenson, PW; Olsson, AG | 1 |
Columbano, A; Ledda-Columbano, GM; Leoni, VP; Mattu, S; Perra, A; Pibiri, M; Puliga, E; Szydlowska, M | 1 |
Zucchi, R | 1 |
1 review(s) available for triiodothyronine and kb 2115
Article | Year |
---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyronines; Drug Design; Dyslipidemias; Humans; Liver Diseases; Male; Mice; Mutation; Non-alcoholic Fatty Liver Disease; Phenols; Pyridazines; Rats; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Thyroid Hormones; Thyronines; Triiodothyronine; Uracil | 2020 |
2 trial(s) available for triiodothyronine and kb 2115
Article | Year |
---|---|
Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.
Topics: Adult; Anilides; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Middle Aged; Thyroid Hormones; Triglycerides; Triiodothyronine | 2010 |
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotirome.
Topics: Anilides; Anticholesteremic Agents; Apolipoproteins B; Blood Pressure; Bone and Bones; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Thyrotropin; Triglycerides; Triiodothyronine | 2015 |
7 other study(ies) available for triiodothyronine and kb 2115
Article | Year |
---|---|
Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
Topics: Animals; Arginine; Cholesterol; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Dyslipidemias; Humans; Indans; Ligands; Liver; Male; Malonates; Models, Molecular; Molecular Mimicry; Molecular Structure; Rats; Rats, Wistar; Small Molecule Libraries; Structure-Activity Relationship; Thyroid Hormone Receptors beta | 2012 |
Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists.
Topics: Animals; Indoles; Rats; Thyroid Hormone Receptors beta | 2014 |
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dys
Topics: Animals; Bone Density; Clinical Trials as Topic; Drug Discovery; Dyslipidemias; Humans; Male; Mice; Mice, Inbred C57BL; Pyridazines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thyroid Hormone Receptors beta; Uracil | 2014 |
[Thyroid hormone analogs: an important biological supply and new therapeutic possibilities].
Topics: Acetates; Anilides; Anticholesteremic Agents; Humans; Hypolipidemic Agents; Phenols; Phenyl Ethers; Phenylacetates; Receptors, Thyroid Hormone; Signal Transduction; Thyroid Hormones; Triiodothyronine | 2008 |
Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.
Topics: Acetates; Anilides; Animals; Apolipoproteins B; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Feces; Lipoproteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenols; Receptors, LDL; Receptors, Thyroid Hormone; Thyroid Hormone Receptors beta; Triglycerides; Triiodothyronine | 2012 |
Thyroid hormone status regulates the expression of secretory phospholipases.
Topics: Anilides; Animals; Gene Expression Regulation, Enzymologic; Group II Phospholipases A2; Hep G2 Cells; Hepatocytes; Humans; Hyperlipidemias; Hyperthyroidism; Hypothyroidism; Inflammation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Phospholipases A2, Secretory; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thyroid Hormone Receptors beta; Triiodothyronine | 2014 |
The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation.
Topics: Anilides; Animal Feed; Animals; Apoptosis; Body Weight; Cell Proliferation; Cyclin D1; Heart; Hepatocytes; Liver; Male; Organ Size; Rats; Rats, Inbred F344; Receptors, Thyroid Hormone; Regenerative Medicine; Time Factors; Transaminases; Triiodothyronine | 2017 |